title: Treatment with statins may be considered in ESRD patients for primary prevention of cardiovascular disease.
authors.affiliation: Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy.
authors.forename: Simone
authors.initials: S
authors.lastname: Manca-di-Villahermosa
authors.affiliation: Department of Internal Medicine, Tor Vergata University, Rome, Italy, and Nephrology and Dialysis Unit, Tor Vergata University Hospital, Rome, Italy. Electronic address: taccone.gallucci@med.uniroma2.it.
authors.forename: Massimo
authors.initials: M
authors.lastname: Taccone-Gallucci
authors.affiliation: Department of Biomedical Sciences, University of Teramo, Italy, and European Center for Brain Research (CERC)/S. Lucia Foundation, Rome, Italy.
authors.forename: Mauro
authors.initials: M
authors.lastname: Maccarrone
mesh_terms: D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D006435:Renal Dialysis
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors